FDA approves dalbavancin for acute bacterial skin infectionsMay 23, 2014DermatologyInfectious Diseases
Survey: Anti-MRSA drugs routinely prescribed for simple abscessesFebruary 4, 2014DermatologyInfectious Diseases
Case Studies in Toxicology: The Acclaimed Zombie-Apocalypse Drug—Is it Just an Illusion?February 1, 2014ToxicologyDermatology
Canadian agency reports rare, severe skin reactions to cancer drug December 4, 2013OncologyDermatologyGastroenterology
FDA updates clobazam label to reflect risk of severe skin reactions December 3, 2013PediatricsNeurologyDermatologyMental Health
Inpatient dermatologist offers three rules to diagnose by October 25, 2013DermatologyBusiness of Medicine
Referral approach promotes next-day ID consultation for cellulitisOctober 17, 2013Infectious DiseasesDermatology
